RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Talkmed Group Stock

Talkmed Group P/S 2025

Talkmed Group P/S

7.62

Ticker

5G3.SI

ISIN

SG2G61000003

As of May 18, 2025, Talkmed Group's P/S ratio stood at 7.62, a 26.16% change from the 6.04 P/S ratio recorded in the previous year.

The Talkmed Group P/S history

Talkmed Group Aktienanalyse

What does Talkmed Group do?

Talkmed Group Ltd. is a leading healthcare company in Asia specializing in the development, manufacturing, and marketing of innovative diagnostic and therapeutic solutions in oncology. The company was founded in 2002 by Dr. Ang Peng Tiam, with a focus on providing high-quality cancer treatments. Since its inception, Talkmed Group Ltd. has become a pioneer in cancer research and treatment in Asia and has grown to become one of the largest providers of cancer treatments in the region. The company's business model is centered around offering high-quality diagnostic solutions and innovative cancer therapies to provide better patient care. They work closely with pharmaceutical companies to develop and market innovative medications and therapies that contribute to higher survival rates and improved quality of life for cancer patients. In addition, Talkmed Group Ltd. is involved in the development of medical diagnostic and monitoring devices tailored to the needs of cancer patients. They offer a range of treatments and programs that aim to provide accessible, affordable, and high-quality care for cancer patients. Overall, Talkmed Group Ltd. is an innovative company dedicated to improving the lives of cancer patients through the development, manufacturing, and marketing of diagnostic and therapeutic solutions in oncology. Talkmed Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Talkmed Group's P/S Ratio

Talkmed Group's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Talkmed Group's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Talkmed Group's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Talkmed Group’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Talkmed Group stock

What is the price-to-earnings ratio of Talkmed Group?

The price-earnings ratio of Talkmed Group is currently 7.62.

How has the price-earnings ratio of Talkmed Group changed compared to last year?

The price-to-earnings ratio of Talkmed Group has increased by 26.16% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Talkmed Group high compared to other companies?

Yes, the price-to-earnings ratio of Talkmed Group is high compared to other companies.

How does an increase in the price-earnings ratio of Talkmed Group affect the company?

An increase in the price-earnings ratio of Talkmed Group would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Talkmed Group affect the company?

A decrease in the price-earnings ratio of Talkmed Group would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Talkmed Group?

Some factors that influence the price-earnings ratio of Talkmed Group are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Talkmed Group pay?

Over the past 12 months, Talkmed Group paid a dividend of 0.02 SGD . This corresponds to a dividend yield of about 5 %. For the coming 12 months, Talkmed Group is expected to pay a dividend of 0.02 SGD.

What is the dividend yield of Talkmed Group?

The current dividend yield of Talkmed Group is 5 %.

When does Talkmed Group pay dividends?

Talkmed Group pays a quarterly dividend. This is distributed in the months of May, September, May, September.

How secure is the dividend of Talkmed Group?

Talkmed Group paid dividends every year for the past 11 years.

What is the dividend of Talkmed Group?

For the upcoming 12 months, dividends amounting to 0.02 SGD are expected. This corresponds to a dividend yield of 5 %.

In which sector is Talkmed Group located?

Talkmed Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Talkmed Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Talkmed Group from 8/22/2024 amounting to 0.009 SGD, you needed to have the stock in your portfolio before the ex-date on 8/14/2024.

When did Talkmed Group pay the last dividend?

The last dividend was paid out on 8/22/2024.

What was the dividend of Talkmed Group in the year 2024?

In the year 2024, Talkmed Group distributed 0.024 SGD as dividends.

In which currency does Talkmed Group pay out the dividend?

The dividends of Talkmed Group are distributed in SGD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Talkmed Group

Our stock analysis for Talkmed Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Talkmed Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.